Caxton »

Enliven Therapeutics shares owned by Caxton

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Caxton from 13F filings

Historical chart of Caxton investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Caxton

Quarter filed Position value Share count Share price at filing
2025-09-30 $268k 13k 20.47
2025-06-30 $263k 13k 20.06